3. Umbruch 4.4..2005 - Online Pot

Cannabinoids in neurodegeneration and neuroprotection 105
86 Polazzi E, Gianni T, Contestabile A (2001) Microglial cells protect cerebellar granule neurons
from apoptosis: evidence for reciprocal signaling. Glia 36: 271–280
87 Molina-Holgado F, Pinteaux E, Moore JD, Molina-Holgado E, Guaza C, Gibson RM, Rothwell
NJ (2003) Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective
actions of cannabinoids in neurons and glia. J Neurosci 23: 6470–6474
88 Skaper SD, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L, Leon A (1996) The
ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a
delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl
Acad Sci USA 93: 3984–3989
89 Sánchez C, de Ceballos ML, del Pulgar TG, Rueda D, Corbacho C, Velasco G, Galve-Roperh I,
Huffman JW, Ramon y Cajal S, Guzman M (2001) Inhibition of glioma growth in vivo by selective
activation of the CB2 cannabinoid receptor. Cancer Res 61: 5784–5789
90 Nuñez E, Benito C, Pazos MR, Barbachano A, Fajardo O, González S, Tolón RM, Romero J
(2004) Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human
brain: an immunohistochemical study. Synapse 53: 208–213
91 Benveniste EN, Nguyen VT, O’Keefe GM (2001) Immunological aspects of microglia: relevance
to Alzheimer’s disease. Neurochem Int 39: 381–391
92 Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, Mackie K, Stella N (2003)
Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23:
1398–1405
93 Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister SL, Campbell
WB, Hillard CJ (2004) Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol,
which increases proliferation via a CB2 receptor-dependent mechanism. Mol
Pharmacol 65: 999–1007
94 Giulian D (1999) Microglia and the immune pathology of Alzheimer disease. Am J Hum Genet
65: 13–18
95 Rubanyi GM, Polokoff MA (1994) Endothelins: molecular biology, biochemistry, pharmacology,
physiology, and pathophysiology. Pharmacol Rev 46: 325–415
96 Schinelli S (2002) The brain endothelin system as potential target for brain-related pathologies.
Curr Drug Targets CNS Neurol Disord 1: 543–553
97 Wagner JA, Varga K, Kunos G (1998) Cardiovascular actions of cannabinoids and their generation
during shock. J Mol Med 76: 824–836
98 Randall MD, Harris D, Kendall DA, Ralevic V (2002) Cardiovascular effects of cannabinoids.
Pharmacol Ther 95: 191–202
99 Mechoulam R, Spatz M, Shohami E (2002) Endocannabinoids and neuroprotection. Sci STKE
129/RE5
100 Chen Y, McCarron RM, Ohara Y, Bembry J, Azzam N, Lenz FA, Shohami E, Mechoulam R,
Spatz M (2000) Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid)
interacts with endothelin-1. Circ Res 87: 323–327
101 Hillard CJ (2000) Endocannabinoids and vascular function. J Pharmacol Exp Ther 294: 27–32
102 Graham DI, McIntosh TK, Maxwell WL, Nicoll JA (2000) Recent advances in neurotrauma. J
Neuropathol Exp Neurol 59: 641–651
103 Janardhan V, Qureshi AI (2004) Mechanisms of ischemic brain injury. Curr Cardiol Rep 6:
117–123
104 Alexi T, Borlongan CV, Faull RL, Williams CE, Clark RG, Gluckman PD, Hughes PE (2000)
Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s disease.
Prog Neurobiol 60: 409–470
105 Moosmann B, Behl C (2002) Antioxidants as treatment for neurodegenerative disorders. Expert
Opin Invest Drugs 11: 1407–1435
106 Rodnitzky RL (1999) Can calcium antagonists provide a neuroprotective effect in Parkinson’s
disease? Drugs 57: 845–849
107 Galea E, Heneka MT, Dello Russo C, Feinstein DL (2003) Intrinsic regulation of brain inflammatory
responses. Cell Mol Neurobiol 23: 625–635
108 Gagliardi RJ (2000) Neuroprotection, excitotoxicity and NMDA antagonists. Arq Neuropsiquiatr
58: 583–588
109 Louw DF, Yang FW, Sutherland GR (2000) The effect of D9-tetrahydrocannabinol on forebrain
ischemia in rat. Brain Res 857: 183–187
110 Mauler F, Mittendorf J, Horvath E, De Vry J (2002) Characterization of the diarylether sul-